Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
Chief Medical Officer
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Laval, Quebec, Canada
- Facility name not stated
Gothenburg, Sweden
- Facility name not stated
Linköping, Sweden
- Facility name not stated
Malmö, Sweden
- Facility name not stated
Stockholm, Sweden
- Facility name not stated
Umeå, Sweden
- Facility name not stated
Escondido, California, United States
- Facility name not stated
Fresno, California, United States
- Facility name not stated
Irvine, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Torrance, California, United States
- Facility name not stated
Tustin, California, United States
- Facility name not stated
Walnut Creek, California, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Decatur, Georgia, United States
- Facility name not stated
Idaho Falls, Idaho, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Butte, Montana, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 30 Nov 2014
- Completion
- 31 Jan 2015
- Last update posted
- 30 Jan 2015
- Registered enrollment
- 250
- Registry id
- NCT01681290
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.